Gómez Marciana Alodia, Villafaina Antonio, Hernández Jesús, Salgado Rosa María, González Miguel Angel, Rodríguez Jesús, Martínez de la Concha Manuel, Tarriño Alejandra, Gervasini Guillermo, Carrillo Juan Antonio
Centro de Salud de Olivenza, Olivenza (Badajoz), Spain.
Ann Pharmacother. 2009 Feb;43(2):339-46. doi: 10.1345/aph.1L242. Epub 2009 Feb 3.
According to the Second Consensus of Granada (2002), the term drug-related problem (DRP) is defined as a health problem resulting from pharmacotherapy and is considered a negative clinical outcome (ie, a therapeutic objective is not achieved or adverse effects are reported). DRP classification systems used in primary care settings can be useful tools to detect, evaluate, and resolve DRPs.
To encourage appropriate drug use in the ambulatory clinical setting through DRP detection and evaluation by means of the Spanish DRP classification system, and to document how pharmacists can help resolve DRPs through interventions with both general practitioners (GPs) and patients.
Four pharmacists investigated DRPs in polymedicated patients over a 6-month period. All detected DRPs were grouped into 3 major categories: necessity, effectiveness, and safety. To resolve DRPs, pharmacists performed interventions on GPs and patients. GPs received verbal and written information about DRPs; patient interventions were in the form of private meetings on health education.
Four hundred twenty-two patients, 80% of whom were aged 65 years or older, were included in the study. Each patient was taking a mean +/- SD of 8.1 +/- 2.4 medications. Three hundred four medications were associated with 245 DRPs; medications indicated for digestive/metabolic or cardiovascular pathologies were the most prevalent. Most (60%) of the identified DRPs belonged to the effectiveness category, whereas safety issues accounted for 28.6%. The most frequently reported DRP was pathology resistant to treatment (19.6%), followed by nonadherence (16.3%). Of the 215 interventions carried out to resolve these DRPs, 173 (80.5%) were addressed to GPs, who agreed to change therapy regimens on 90.2% of the occasions. Forty-two (19.5%) interventions were addressed to patients. Furthermore, the interventions accepted by GPs and patients resolved 176 (82%) DRPs.
The current Spanish DRP classification system is a useful tool to systematically detect and document DRPs in daily general practice. In addition, the interventions addressed by pharmacists to GPs and patients resolved most of the detected DRPs.
根据《格拉纳达第二次共识》(2002年),药物相关问题(DRP)这一术语被定义为由药物治疗引起的健康问题,并被视为负面临床结果(即未实现治疗目标或报告了不良反应)。基层医疗环境中使用的DRP分类系统可能是检测、评估和解决DRP的有用工具。
通过西班牙DRP分类系统检测和评估DRP,鼓励在门诊临床环境中合理用药,并记录药剂师如何通过对全科医生(GP)和患者进行干预来帮助解决DRP。
四名药剂师在6个月内对使用多种药物的患者的DRP进行了调查。所有检测到的DRP被分为三大类:必要性、有效性和安全性。为了解决DRP,药剂师对全科医生和患者进行了干预。全科医生收到了关于DRP的口头和书面信息;对患者的干预采取健康教育私人会面的形式。
422名患者纳入研究,其中80%年龄在65岁及以上。每位患者平均服用8.1±2.4种药物。304种药物与245个DRP相关;用于消化/代谢或心血管疾病的药物最为常见。大多数(60%)已识别的DRP属于有效性类别,而安全问题占28.6%。最常报告的DRP是对治疗耐药的疾病(19.6%),其次是不依从(16.3%)。为解决这些DRP而进行的215次干预中,173次(80.5%)针对全科医生,其中90.2%的情况下全科医生同意更改治疗方案。42次(19.5%)干预针对患者。此外,全科医生和患者接受的干预解决了176个(82%)DRP。
当前的西班牙DRP分类系统是在日常全科医疗中系统检测和记录DRP的有用工具。此外,药剂师对全科医生和患者进行的干预解决了大多数检测到的DRP。